Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000241854 | SCV000304251 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000269025 | SCV000410992 | benign | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics Inc | RCV000269025 | SCV000677222 | benign | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | 2017-05-17 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001521143 | SCV001157012 | benign | not provided | 2021-01-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001521143 | SCV001730418 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001521143 | SCV001827691 | benign | not provided | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000269025 | SCV002026910 | benign | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001785529 | SCV002026911 | benign | Lateral meningocele syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000269025 | SCV001245244 | not provided | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 06-21-2005 by Lab or GTR ID 1012. GenomeConnect-CureCADASIL assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. | |
Diagnostic Laboratory, |
RCV000241854 | SCV001744534 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000241854 | SCV001806965 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000241854 | SCV001967517 | benign | not specified | no assertion criteria provided | clinical testing |